Loading people...
Loading people...
Principal at Jazz Venture Partners
Amanda Way is a Principal at Jazz Venture Partners, a venture capital firm specializing in early-stage investments in health, wellness, and human performance technologies.
Amanda Way invests in early-stage companies focused on health, wellness, and human performance. Her areas of interest include digital health, biotech, AI in health, and solutions leveraging neuroscience and behavioral science.
Amanda Way works as a Principal at Jazz Venture Partners.
Amanda Way is a Principal at Jazz Venture Partners and the Co-Founder and Chief AI Officer of LiveX AI, based in San Francisco, California. Prior to her current roles, she spent over five years in venture capital, including a tenure at Emerson Collective where she expanded the firm's investments across the biotechnology and healthcare sectors with a specific focus on cancer patient impact. She previously worked in healthcare executive search and early-stage investing at Oxeon Partners, identifying leadership for high-growth medical technology companies. Way holds a Bachelor of Arts from Princeton University and pursued a Master's in Clinical Informatics Management at Stanford Medicine to deepen her technical expertise in complex healthcare systems. Her current investment and operational focus centers on leveraging artificial intelligence, clinical informatics, and neuroscience to advance early-stage digital health and human performance startups.
Amanda Way serves as a Principal at Jazz Venture Partners, a distinguished venture capital firm renowned for its focus on human performance and health innovation. In her pivotal role, Amanda is deeply involved in sourcing, evaluating, and supporting early-stage companies that are at the forefront of transforming human potential. Her expertise lies in identifying visionary founders and breakthrough technologies that promise to reshape how individuals optimize their health, well-being, and cognitive capabilities.
Amanda's investment focus is broad yet specialized, encompassing critical areas within health, wellness, and human performance. She is particularly keen on ventures that harness the power of neuroscience and behavioral science to create impactful solutions. This includes pioneering digital health platforms, innovative biotech solutions, and AI-driven technologies designed to enhance mental acuity, physical resilience, and overall quality of life. Her portfolio interests often include companies developing personalized health interventions, advanced wearable technologies, and platforms that promote cognitive fitness and emotional intelligence.
Before joining Jazz Venture Partners, Amanda cultivated a robust background in the venture capital landscape, honing her analytical skills and market insights. Her prior experiences equipped her with a keen ability to dissect complex market trends and identify disruptive opportunities. This foundation allows her to provide invaluable strategic guidance to portfolio companies, helping them navigate the challenges of early-stage growth and scale effectively. She is known for her collaborative approach, working closely with founders to refine their strategies, build strong teams, and achieve significant milestones.
While specific notable investments are often confidential in early-stage venture, Amanda has been instrumental in contributing to Jazz Venture Partners' success in backing companies that have gone on to achieve significant impact. Her contributions have helped propel firms developing cutting-edge solutions in areas like stress reduction, sleep optimization, and athletic performance enhancement. Amanda's commitment extends beyond capital; she acts as a true partner to entrepreneurs, leveraging her network and expertise to foster innovation and drive market leadership. Her dedication to advancing human potential through strategic investment makes her a key figure in the venture capital ecosystem.
